ArticleDermatology and therapyPublished
Efficacy and Safety of the PD-1 Agonist JNJ-67484703 in Participants with Atopic Dermatitis: Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial Results
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Dermatology and therapy
- Published
- Topic
- Clinical care
- Subject terms
- Pharmacodynamics; Atopic Dermatitis; Programmed Cell Death Protein 1; Jnj-67484703
- PubMed ID
- 42008057
- PubMed Central ID
- PMC13237295
- Open access
- Yes, open
- Added to directory
- Source checked